Dexamethasone increases ubiquitin transcription through an SP-1 dependent mechanism in multiple myeloma cells

Leukemia Research

Volumn 32, Issue 9, 2008, Pages 1480-1482

  Mao, Xinliang ^a   Zhu, Xuegong ^a   Hurren, Rose ^a   Ezzat, Shereen ^a   Schimmer, Aaron D ^a  

^a Ontario Cancer Institute   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYCLIN D2; DEXAMETHASONE; GLUCOCORTICOID; MESSENGER RNA; MITHRAMYCIN; PROTEASOME; PROTEASOME INHIBITOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR C MAF; TRANSCRIPTION FACTOR SP 1; UBIQUITIN C;

CELL DEATH; CELL LEVEL; CHROMATIN IMMUNOPRECIPITATION; DRUG MECHANISM; GENE CONTROL; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; IMMUNOBLOTTING; INCUBATION TIME; LETTER; MULTIPLE MYELOMA; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UBIQUITINATION; UPREGULATION;

DEXAMETHASONE; GLUCOCORTICOIDS; HUMANS; MULTIPLE MYELOMA; PROMOTER REGIONS (GENETICS); SP1 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; UBIQUITIN;

EID: 43049152816     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2007.11.031     Document Type: Letter

References (7)

1. Mao X., Stewart A.K., Hurren R., Datti A., Zhu X., Zhu Y., et al. A chemical biology screen identifies glucocorticoids that regulate c-maf expression by increasing its proteasomal degradation through upregulation of ubiquitin. Blood 110 12 (2007) 4047-4054
2. Nenoi M., Cartwright I.L., Mita K., and Ichimura S. Comparison of the 5′ upstream region of the evolutionarily equivalent polyubiquitin gene of humans and Chinese hamsters. Gene 179 2 (1996) 297-299
3. Marinovic A.C., Zheng B., Mitch W.E., and Price S.R. Ubiquitin (UbC) expression in muscle cells is increased by glucocorticoids through a mechanism involving SP-1 and MEK1. J Biol Chem 277 19 (2002) 16673-16681
4. Blume S.W., Snyder R.C., Ray R., Thomas S., Koller C.A., and Miller D.M. Mithramycin inhibits SP-1 binding and selectively inhibits transcriptional activity of the dihydrofolate reductase gene in vitro and in vivo. J Clin Invest 88 5 (1991) 1613-1621
5. Snyder R.C., Ray R., Blume S., and Miller D.M. Mithramycin blocks transcriptional initiation of the c-myc P1 and P2 promoters. Biochemistry 30 17 (1991) 4290-4297
6. Ray R., Snyder R.C., Thomas S., Koller C.A., and Miller D.M. Mithramycin blocks protein binding and function of the SV40 early promoter. J Clin Invest 83 6 (1989) 2003-2007
7. Marinovic A.C., Zheng B., Mitch W.E., and Price S.R. Tissue-specific regulation of ubiquitin (UbC) transcription by glucocorticoids: in vivo and in vitro analyses. Am J Physiol Renal Physiol 292 2 (2007) 660-666